News/ News/ R&D Novartis’ transplant drug hope iscalimab flunks mid-stage trial Phil Taylor antibody, immunology, iscalimab, Novartis, R&D, transplant 0 Comment Novartis hopes of improving on tacrolimus as the standard drug for preventing organ rejection in transplant patients have Share X Novartis’ transplant drug hope iscalimab flunks mid-stage trial https://pharmaphorum.com/news/novartis-transplant-drug-hope-iscalimab-flunks-mid-stage-trial/
antibody, immunology, iscalimab, Novartis, R&D, transplant
0 Comment
